NCT01642394

Brief Summary

Main objective:To evaluate the effectiveness of the "Diabetes Self-Management Programme" (DSMP) on the metabolic control, cardiovascular risk reduction, quality of life and self-efficacy in adult patients with type 2 diabetes, compared with current standard care of patients with type 2 diabetes, in the context of Osakidetza's Primary Care network. Secondary objectives:

  • To evaluate the impact of the implementation of DSMP in the use of health services.
  • To assess the impact of DSMP in the cost of treatment of the involved population.
  • To evaluate the improvement in physical activity and diet patterns among the participants.
  • To describe the feasibility of implementing the DSMP in the Basque Country's primary health care system Methodology: Randomized clinical trial in which patients diagnosed with type 2 diabetes aged between 18 and 80 years pertaining to 4 primary regions of the Basque country, who agree to participate in the study, will be randomly assigned to two groups: the intervention group (the DSMP programme) and the control group. The intervention will be performed by trained patients with type 2 diabetes and health professionals and it will consist in 6 group sessions of two and a half hours each, on a weekly basis with a overall duration of 6 weeks. The session content includes techniques for dealing with problems, promotion of exercise, nutrition concepts, proper use of medication, effective communication and basic knowledge about diabetes and its complications. The sessions are supported with educational material. The main outcome is the improvement of HbA1c (glycated hemoglobin) levels. Secondary outcomes are reduction of cardiovascular risk, increase of quality of life and self-efficacy. The results will be analyzed at 6, 12 and 24 months after the intervention. Hypothesis: An educational intervention on patients with type 2 diabetes mellitus based on the program DSMP conducted by previously trained lay persons and health professionals, improve metabolic control as measured on a 0.5% decrease in Hb A1c (Clar, 2010),compared to regular health education. On the other hand, it is expected to see improvements in the quality of life for these patients. The intervention may reduce the weight and cardiovascular risk due to changes in the physical activity and diet patterns, getting to a more appropriate use of health services and medication. It is expected that changes in the variables occur 6 months after the intervention and remain over the time

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
594

participants targeted

Target at P75+ for not_applicable diabetes-mellitus

Timeline
Completed

Started Oct 2011

Longer than P75 for not_applicable diabetes-mellitus

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2011

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 16, 2012

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 17, 2012

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2014

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

November 17, 2017

Status Verified

November 1, 2017

Enrollment Period

3.2 years

First QC Date

May 16, 2012

Last Update Submit

November 15, 2017

Conditions

Keywords

Diabetes MellitusChronic DiseaseEducationPrimary CareSelf careSelf Management

Outcome Measures

Primary Outcomes (1)

  • Change in Glycated hemoglobin

    The investigators are going to measure the diference between basal Glycated Hemoglobin and 6,12 and 24 months Glycated Hemoglobin.

    Measurements will be carried out before intervention and 6, 12 and 24 months after intervention

Secondary Outcomes (16)

  • Change in Cardiovascular risk

    Measurements will be carried out before intervention and 6, 12 and 24 months after intervention

  • Change in quality of life

    Measurements will be carried out before intervention and 6, 12 and 24 months after intervention

  • Change in self efficacy

    Measurements will be carried out before intervention and 6, 12 and 24 months after intervention

  • Change in health services utilization

    Measurements will be carried out before intervention and 6, 12 and 24 months after intervention

  • Introduction or removal of hypoglycaemic drugs

    Measurements will be carried out before intervention and 6, 12 and 24 months after intervention

  • +11 more secondary outcomes

Study Arms (2)

Standardized care

NO INTERVENTION

The control group will receive usual care for secondary prevention of type 2 diabetes according to usual care in Osakidetza's primary care.

Self-management education programme

EXPERIMENTAL

Attendees will receive the Diabetes Self-Management Programme in spanish version (Manejo personal de la diabetes).

Behavioral: Diabetes Self-Management Program

Interventions

The intervention will be performed by patients with type 2 diabetes and health professionals and it will be divided in 6 group sessions for two and a half hours each, on a weekly basis for 6 weeks. The session content includes techniques for dealing with problems in general, promotion of exercise, nutrition concepts, proper use of medication, effective communication and basic knowledge about diabetes and its complications. The sessions are supported with educational material. Two leaders, previously trained in the DSMP, will lead each group. The leading status (patient or health care professional) is obtained after attending a 6-week structured program of training, a successful completion of 4 days of training sessions, and taking part in a full course for patients with a proven leader.

Also known as: Diabetes Self-Management Programme
Self-management education programme

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults over 18 years from four primary regions of the Basque Country: Araba, Bidasoa, Ezkerraldea- Enkarterri, Ekialde, with type 2 diabetes who have agreed to participate in the "Active Patient".

You may not qualify if:

  • Adults over 80 years or patients with mental disorder that distorts reality (schizophrenia, bipolar disorder, Alzheimer's disease, psychosis, dementia) or morbidity which can interfere with the course, like chronic patients at home.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Osakidetza

Vitoria-Gasteiz, Alava, 01006, Spain

Location

Related Publications (3)

  • Gamboa Moreno E, Mateo-Abad M, Ochoa de Retana Garcia L, Vrotsou K, Del Campo Pena E, Sanchez Perez A, Martinez Carazo C, Arbonies Ortiz JC, Rua Portu MA, Pinera Elorriaga K, Zenarutzabeitia Pikatza A, Urquiza Bengoa MN, Mendez Sanpedro T, Oses Portu A, Aguirre Sorondo MB, Rotaeche Del Campo R; Osakidetza Active Patient Research Group. Efficacy of a self-management education programme on patients with type 2 diabetes in primary care: A randomised controlled trial. Prim Care Diabetes. 2019 Apr;13(2):122-133. doi: 10.1016/j.pcd.2018.10.001. Epub 2018 Nov 6.

  • Gamboa Moreno E, Ochoa de Retana Garcia L, Del Campo Pena ME, Sanchez Perez A, Martinez Carazo C, Arbonies Ortiz JC, Rua Portu MA, Pinera Elorriaga K, Zenarutzabeitia Pikatza A, Urquiza Bengoa MN, Mendez Sanpedro T, Oses Portu A, Gorostidi Fano L, Aguirre Sorondo MB, Vrotsou K, Rotaeche Del Campo R. A Pilot Study to Assess the Feasibility of the Spanish Diabetes Self-Management Program in the Basque Country. J Diabetes Res. 2016;2016:9145673. doi: 10.1155/2016/9145673. Epub 2016 Dec 29.

  • Gamboa Moreno E, Sanchez Perez A, Vrotsou K, Arbonies Ortiz JC, Del Campo Pena E, Ochoa de Retana Garcia L, Rua Portu MA, Pinera Elorriaga K, Zenarutzabeitia Pikatza A, Urquiza Bengoa MN, Sanz Echave R, Mendez Sampedro T, Oses Portu A, Gorostidi Fano L, Aguirre Sorondo MB, Rotaeche Del Campo R; Osakidetza Active Patient Research Group. Impact of a self-care education programme on patients with type 2 diabetes in primary care in the Basque Country. BMC Public Health. 2013 May 29;13:521. doi: 10.1186/1471-2458-13-521.

Related Links

MeSH Terms

Conditions

Diabetes MellitusChronic Disease

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Estibaliz Gamboa Moreno, Nurse

    Osakidetza

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Intervention group The complete intervention consists of group sessions (8 to 15 people) lasting 2.5 hours, once a week for six weeks. These sessions are structured with the aim of enabling participants to acquire knowledge and skills related to the disease and its management, placing a strong emphasis on proactive tools to achieve healthier lifestyles (in terms of diet, physical exercise, management of emotions, and correct use of medication, among others). Control group Patients assigned to the control group will receive usual care for secondary prevention of DM2 in accordance with the Osakidetza primary care protocols, which are based on clinical practice guidelines.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Diploma of Nursing

Study Record Dates

First Submitted

May 16, 2012

First Posted

July 17, 2012

Study Start

October 1, 2011

Primary Completion

December 30, 2014

Study Completion

December 1, 2016

Last Updated

November 17, 2017

Record last verified: 2017-11

Data Sharing

IPD Sharing
Will not share

Locations